Glaxosmithkline Pharmaceuticals informs about disclosure

28 Oct 2023 Evaluate
Glaxosmithkline Pharmaceuticals has informed that the Company has received a Notice from Kerala State GST authorities, seeking to disallow transitional Excise duty credit (TRAN 1 credit) claimed in Kerala State. Relevant details are enclosed. Since this issue in procedural in nature, the Company is settling the issue basis internal assessment. There is a penalty of Rs.40,635 which is also procedural in nature under Section 73 of GST Act and not specific to any suppression, willful misstatement done by the Company.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2476.65 11.75 (0.48%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×